Endotoxin modulates the capacity of CpG-activated liver myeloid DC to direct Th1-type responses

European Journal of Immunology

Volumn 36, Issue 9, 2006, Pages 2483-2493

  Abe, Masanori ^a   Tokita, Daisuke ^a   Raimondi, Giorgio ^a   Thomson, Angus W ^a  

^a UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

Author keywords

CpG; DC; IL 12; Liver; LPS

Indexed keywords

CPG OLIGODEOXYNUCLEOTIDE; ENDOTOXIN; GAMMA INTERFERON; IMIQUIMOD; INTERLEUKIN 12; LIPOPOLYSACCHARIDE; TOLL LIKE RECEPTOR 4;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CELL ACTIVATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CROSS TOLERANCE; CYTOKINE PRODUCTION; CYTOKINE RELEASE; DENDRITIC CELL; DOWN REGULATION; IMMUNOLOGICAL TOLERANCE; IMMUNOMODULATION; IN VITRO STUDY; IN VIVO STUDY; LIVER; MALE; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; SPLEEN; T LYMPHOCYTE ACTIVATION; TH1 CELL;

ADJUVANTS, IMMUNOLOGIC; AMINOQUINOLINES; ANIMALS; ANTIGENS, CD11C; CPG ISLANDS; DENDRITIC CELLS; ENDOTOXINS; FLOW CYTOMETRY; IMMUNE TOLERANCE; INTERFERON TYPE II; INTERLEUKIN-12; LIVER; LYMPHOCYTE ACTIVATION; MALE; MEMBRANE GLYCOPROTEINS; MICE; SPLEEN; TH1 CELLS; TOLL-LIKE RECEPTOR 7; TOLL-LIKE RECEPTOR 9;

EID: 33748860233     PISSN: 00142980     EISSN: None     Source Type: Journal    
DOI: 10.1002/eji.200535767     Document Type: Article

References (53)

1. Iwasaki, A. and Medzhitov, R., Toll-like receptor control of the adaptive immune responses. Nat. Immunol. 2004. 5:987-995.
2. Akira, S. and Takeda, K., Toll-like receptor signalling. Nat. Rev. Immunol. 2004. 4: 499-511.
3. Banchereau, J. and Steinman, R. M., Dendritics cells and the control of immunity. Nature 1998. 392: 245-252.
4. Trinchieri, G., Interleukin-12 and the regulation of innate resistance and adaptive immunity. Nat. Rev. Immunol. 2003. 3:133-146.
5. Krieg, A. M., CpG motifs in bacterial DNA and their immune effects. Annu. Rev. Immunol. 2002.20: 709-760.
6. Klinman, D. M., Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat. Rev. Immunol. 2004. 4: 249-258.
7. Halperin, S. A., Van Nest, G., Smith, B., Abtahi, S., Whiley, H. and Eiden, J. J., A phase I study of the safety and immunogenecity of recombinant hepatitis B surface antigen co-administered with an immunostimulatory phosphorothioate oligonucleotide adjuvant. Vaccine 2003. 21: 2461-2467.
8. Siegrist, C. A., Pihlgren, M., Tougne, C., Efler, S. M., Morris, M. L., AlAdhami, M. J., Cameron, D. W. et al., Co-administration of CpG oligonucleotides enhances the late affinity maturation process of human anti-hepatitis B vaccine response. Vaccine 2004. 615-622.
9. Krieg, A. M., A role for Toll in autoimmunity. Nat. Immunol. 2002. 3: 423-424.
10. Ichikawa, H. T., Williams, L. P. and Segal, B. M., Activation of APCs through CD40 or Toll-like receptor 9 overcomes tolerance and precipitates autoimmune disease. J. Immunol. 2002. 169: 2781-2787.
11. Waldner, H., Collins, M. and Kuchroo, V. K., Activation of antigen-presenting cells by microbial products breaks self tolerance and induces autoimmune disease. J. Clin. Invest. 2004. 113: 990-997.
12. Sacher, T., Knolle, P., Nichterlein, T., Arnold, B., Hammerling, G. J. and Limmer, A., CpG-ODN-induced inflammation is sufficient to cause T-cell-mediated autoagression against hepatocytes. Eur. J. Immunol. 2002. 32: 3628-3637.
13. Jones, D.E., Palmer, J. M., Burt A. D., Walker, C., Robe, A. J. and Kirby, J. A., Bacterial motif DNA as an adjuvant for the breakdown of immune self-tolerance to pyruvate dehydrogenase complex. Hepatology 2002. 36: 679-686.
14. Kikuchi, K., Lian, Z. X., Yang, G. X., Ansari, A. A., Ikehari, S., Kaplan, M., Miyakawa, H. et al., Bacterial CpG induces hyper-IgM production in CD27(+) memory B cells in primary biliary cirrhosis. Gastroenterology 2005. 128: 304-312.
15. Mao, T.K., Lian, Z. X., Selmi, C., Ichiki, Y., Ashwood, P., Ansari, A. A., Coppel, R. L., et al. Altered monocyte responses to defined TLR ligands in patients with primary billiary cirrhosis. Hepatology 2005. 42: 802-808.
16. Randow, F., Syrbe, U., Meisel, C., Krausch, D., Zuckermann, H., Platzer, C. and Volk, H. D., Mechanism of endotoxin desentization: Involvement of interleukin 10 and transforming growth factor beta. J. Exp. Med. 1995. 181: 1887-1892.
17. Granowitz, E. V., Porat, R., Mier, J. W., Orencole, S. F., Kaplanski. G., Lynch, E. A., Ye, K. et al., Intravenous endotoxin suppresses the cytokine response of peripheral blood mononuclear cells of healthy humans. J. Immunol. 1993. 151: 1637-1645.
18. Angele, M. K. and Faist, E., Clinical review: Immunodepression in the surgical patient and increased susceptibility to infection. Crit. Care 2002. 6: 298-305.
19. Wysocka, M., Robertson, S., Riemann, H., Caamano, J., Hunter, C., Mackiewicz, A., Montaner, L. J. et al., IL-12 suppression during experimental endotoxin tolerance: Dendritic cell loss and macrophage hyporesponsiveness. J. Immunol. 2001. 166: 7504-7513.
20. De Smedt, T., Pajak B., Muraille, E., Lespagnard, L., Heinen, E., De Baetselier, P., Urbain, J. et al., Regulation of dendritic cell numbers and maturation by lipopolysaccharide in vivo. J. Exp. Med. 1996.184:1413-1424.
21. Sato, S., Nomura, F., Kawai, T., Takeuchi, O., Muhlradt, P. F., Takeda, K. and Akira, S., Synergy and cross-tolerance between Toll-like receptor (TLR) 2- and TLR4-mediated signaling pathways. J. Immunol. 2000. 165: 7096-7101.
22. Wang, J. H., Doyle, M., Manning, B. J., Blankson, S., Wu, Q. D., Power, C., Cahill, R. and Redmond, H. P., Cutting edge: Bacterial lipoprotein induces endotoxin-independent tolerance to septic shock. J. Immunol. 2003. 170: 14-18.
23. Yeo, S. J., Yoon, J. G., Hong, S. C. and Yi, A. K., CpG DNA induces self and cross-hyporesponsiveness of RAW264.7 cells in response to CpG DNA and lipopolysaccharide: Alterations in IL-1 receptor-associated kinase expression. J. Immunol. 2003. 170: 1052-1061.
24. Schwartz, D. A., Wohlford-Lenane, C. L., Quinn, T. J. and Krieg, A. M., Bacterial DNA or oligonucleotides containing unmethylated CpG motifs can minimize lipopolysaccharide-induced inflammation in the lower respiratory tract through an IL-12-dependent pathway. J. Immunol. 1999.163: 224-231.
25. Slotta, J. E., Scheuer, C., Menger, M. D. and Vollmar, B., Immunostimulatory CpG-oligodeoxynucleotides (CpG-ODN) induce early hepatic injury, but provide a late window for protection against endotoxin-mediated liver damage. J. Hepatol. 2006. 44: 576-585.
26. Dalpke, A. H., Lehner, M. D., Hartung, T. and Heeg, K., Differential effects of CpG-DNA in Toll-like receptor-2/-4/-9 tolerance and cross-tolerance. Immunology 2005. 116: 203-212.
27. Gao, J. J., Zuvanich, E. G., Xue, Q., Horn, D. L., Silverstein, R. and Morrison, D. C., Cutting edge: Bacterial DNA and LPS act in synergy in inducing nitric oxide production in RAW 264.7 macrophages. J. Immunol. 1999. 163: 4095-4099.
28. Crabtree, T. D., Jin, L., Raymond, D. P., Pelletier, S. J., Houlgrave, C. W., Gleason, T. G., Pruett, T. L. and Sawyer, R. G., Preexposure of routine macrophages to CpG oligonucleotide results in a biphasic tumor necrosis factor alpha response to subsequent lipopolysaccharide challenge. Infect. Immun. 2001. 69: 2123-2129.
29. Yi, A. K., Yoon, J. G., Hong, S. C., Redford, T. W. and Krieg, A. M., Lipopolysaccharide and CpG DNA synergize for tumor necrosis factor-alpha production through activation of NF-kappaB. Int. Immunol. 2001. 13: 1391-1404.
30. An, H., Yu, Y., Zhang, M., Xu, H., Qi, R., Yan, X, Liu, S. et al., Involvement of ERK, p38 and NF-kappaB signal transduction in regulation of TLR2, TLR4 and TLR9 gene expression induced by lipopolysaccharide in mouse dendritic cells. Immunology 2002. 106: 38-45.
31. Napolitani, G., Rinaldi, A., Bertoni, F., Sallusto, F. and Lanzavecchia, A., Selected Toll-like receptor agonist combinations synergistically trigger a T helper type 1-polarizing program in dendritic cells. Nat Immunol. 2005. 6: 769-776.
32. Ardavin, C., Martinez del Hoyo, G., Martin, P., Anjuere, F., Arias, C. F., Marin, A. R., Ruiz, S. et al., Origin and differentiation of dendritic cells. Trends Immunol. 2001. 22: 691-700.
33. Boonstra, A., Asselin-Paturel, C., Gilliet, M., Crain, C., Trinchieri, G., Liu, Y. J. and O'Garra, A., Flexibility of mouse classical and plasmacytoid-derived dendritic cells in directing T helper type 1and 2 cell development: Dependency on antigen dose and differential Toll-like receptor ligation. J. Exp. Med. 2003. 197: 101-109.
34. De Creus, A., Abe, M., Lau, A. H., Hackstein, H., Raimondi, G. and Thomson, A. W., Low TLR4 expression by liver dendritic cells correlates with reduced capacity to activate allogeneic T cells in response to endotoxin. J. Immunol. 2005. 174: 2037-2045.
35. Pillarisetty, V. G., Shah, A. B., Miller, G., Bleier, J. I. and DeMatteo, R. P., Liver dendritic cells are less immunogenic than spleen dendritic cells because of differences in subtype composition. J. Immunol. 2004. 172: 1009-1017.
36. Jomantaite, L, Dikopoulos, N., Kroger, A., Leithauser, F., Hauser, H., Schirmbeck, R. and Reimann, J., Hepatic dendritic cell subsets in the mouse. Eur. J. Immunol. 2004. 34: 355-365.
37. Lian, Z. X., Okada, T., He, X. S., Kita, H., Liu, Y. J., Ansari, A. A., Kikuchi, K. et al., Heterogeneity of dendritic cells in the mouse liver: Identification and characterization of four distinct populations. J. Immunol. 2003. 170: 2323-2330.
38. + lymphoid-related dendritic cells. J. Immunol. 2000. 165: 795-803.
39. Calne, R. Y., Sells, R. A., Pena, J. R., Davis, D. R., Millard, P. R., Herbertson, B. M., Binns, R. M. and Davies, D. A., Induction of immunological tolerance by porcine liver allografts. Nature 1969. 223: 472-476.
40. Qian, S., Demetris, A. J., Murase, N., Rao, A. S., Fung, J. J. and Starzl, T. E., Murine liver allograft transplantation: Tolerance and donor cell chimerism. Hepatology 1994. 19: 916-924.
41. Lau, A. H. and Thomson, A. W., Dendritic cells and immune regulation in the liver. Gut 2003. 52: 307-314.
42. Knolle, P. A. and Gerken, G., Local control of the immune response in the liver. Immunol. Rev. 2000. 174: 21-34.
43. Crispe, I. N., Hepatic T cells and liver tolerance. Nat. Rev. Immunol. 2003. 3: 51-62.
44. Banchereau, J., Briere, F., Caux, C., Davoust J., Lebecque, S., Liu, Y. J., Pulendran, B. and Palucka, K., Immunobiology of dendritic cells. Annu. Rev. Immunol. 2000. 18: 767-811.
45. Lau, A. H., de Creus, A., Lu, L. and Thomson, A. W., Liver tolerance mediated by antigen presenting cells: Fact or fiction? Gut 2003. 52: 1075-1078.
46. Gao, J. J., Diesl, V., Wittmann, T., Morrison, D. C., Ryan, J. L., Vogel, S. N. and Follettie, M. T., Regulation of gene expression in mouse macrophages stimulated with bacterial CpG-DNA and lipopolysaccharide. J. Leukoc. Biol. 2002. 72: 1234-1245.
47. + T-cell responses in vivo after viral stimulation. Blood 2004. 104: 1808-1815.
48. Abe, M., Wang, Z., de Creus, A. and Thomson, A. W., Plasmacytoid. dendritic cell precursors induce allogeneic T-cell hyporesponsiveness and prolong heart graft survival. Am. J. Transplant. 200S. 5: 1808-1819.
49. Abe, M., Zahorchak, A. F., Colvin, B. L. and Thomson, A. W., Migratory responses of murine hepatic myeloid, lymphoid-related, and plasmacytoid dendritic cells to CC chemokines. Transplantation 2004. 78: 762-765.
50. Sanchez-Campillo, M., Chicano, A., Torio, A., Martin-Orozco, E., Gamiz, P., Hernandez-Caselles, T. and Garcia-Penarrubia, P., Implication of CpG-ODN and reactive oxygen species in the inhibition of intracellular growth of Salmonella iyphimurium in hepatocytes. Microbes Infect. 2004. 6: 813-820.
51. Verthelyi, D., Ishii, Y. L. J., Gursel, M., Takeshita, F. and Klinman, D. M., Human peripheral blood cells differentially recognize and respond to two distinct CPG motifs. J. Immunol. 2001. 166: 2372-2377.
52. Hartmann, G., Battiany, J., Poeck, H., Wagner, M., Kerkmann, M., Lubenow, N., Rothenfusser, S. and Endres, S., Rational design of new CpG oligonucleotides that combine B cell activation with high IFN-alpha induction in plasmacytoid dendritic cells. Eur. J. Immunol. 2003. 33: 1633-1641.
53. Abe, M. and Thomson, A. W., Dexamethasone preferentially suppresses plasmacytoid dendritic cell differentiation and enhances their apoptotic death. Clin. Immunol. 2006.118: 300-306.